Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin beta4 in neoplastic diseases
- PMID: 20536450
- DOI: 10.1111/j.1749-6632.2010.05488.x
Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin beta4 in neoplastic diseases
Abstract
The natural tetrapeptide acetyl-ser-asp-lys-pro (AcSDKP) is formed in vivo by enzymatic cleavage of the N terminus of thymosin beta4 by prolyl oligopeptidase (POP). Recently, AcSDKP was shown to promote angiogenesis. Because of the critical role of neovascularization in cancer development, the levels of AcSDKP and POP activity in a number of different malignant tissues were investigated. Our studies revealed that AcSDKP levels were markedly elevated in neoplastic diseases including hematologic malignancies and solid neoplasms. Consistent with this finding, the enhanced activity of POP was also detected in all analyzed specimens of cancer tissues. Both these novel findings are in concert with the previously reported overexpression of thymosin beta4 in a large variety of malignant tumors and with its potential role in cancerogenesis. The physiological relevance of these findings awaits further studies; however, our first results strongly suggest a key role for AcSDKP in the pathogenesis of cancer.
Similar articles
-
Overexpression of the angiogenic tetrapeptide AcSDKP in human malignant tumors.Anticancer Res. 2008 Sep-Oct;28(5A):2813-7. Anticancer Res. 2008. PMID: 19035315
-
AcSDKP regulates cell proliferation through the PI3KCA/Akt signaling pathway.PLoS One. 2013 Nov 7;8(11):e79321. doi: 10.1371/journal.pone.0079321. eCollection 2013. PLoS One. 2013. PMID: 24244481 Free PMC article.
-
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.Br J Pharmacol. 2011 Aug;163(8):1666-78. doi: 10.1111/j.1476-5381.2010.01146.x. Br J Pharmacol. 2011. PMID: 21133893 Free PMC article.
-
Inhibitory peptides in hematopoiesis.Exp Hematol. 1995 Jun;23(6):477-81. Exp Hematol. 1995. PMID: 7768302 Review.
-
Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin beta-4.Ann N Y Acad Sci. 2007 Sep;1112:123-39. doi: 10.1196/annals.1415.019. Epub 2007 May 10. Ann N Y Acad Sci. 2007. PMID: 17495245 Review.
Cited by
-
Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.Neoplasia. 2015 Jan;17(1):43-54. doi: 10.1016/j.neo.2014.11.002. Neoplasia. 2015. PMID: 25622898 Free PMC article.
-
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes.Front Pharmacol. 2014 Apr 14;5:70. doi: 10.3389/fphar.2014.00070. eCollection 2014. Front Pharmacol. 2014. PMID: 24782774 Free PMC article. Review.
-
Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.Oncotarget. 2016 Jun 7;7(23):33841-54. doi: 10.18632/oncotarget.8409. Oncotarget. 2016. PMID: 27029074 Free PMC article.
-
Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.Neoplasia. 2013 Apr;15(4):348-58. doi: 10.1593/neo.121850. Neoplasia. 2013. PMID: 23555181 Free PMC article.
-
Ac-SDKP suppresses TNF-α-induced ICAM-1 expression in endothelial cells via inhibition of IκB kinase and NF-κB activation.Am J Physiol Heart Circ Physiol. 2016 May 1;310(9):H1176-83. doi: 10.1152/ajpheart.00252.2015. Epub 2016 Mar 4. Am J Physiol Heart Circ Physiol. 2016. PMID: 26945075 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources